Univariable analysis of risk factors for DVT/PE and CVT
| . | Univariable analysis of risk factors for any thrombosis . | Univariable analysis of risk factors for DVT/PE . | Univariable analysis of risk factors for CVT . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | OR . | 95% CI . | P . | OR . | 95% CI . | P . | OR . | 95% CI . | P . |
| Age | 1.02 | 1.00-1.03 | .03 | 1.03 | 1.00-1.04 | .01 | .99 | .97-1.02 | .57 |
| Female | 1.50 | 1.00-2.23 | .05 | 1.32 | .84-2.08 | .23 | 1.54 | .76-3.13 | .23 |
| BMI | 1.04 | 1.00-1.08 | .05 | 1.06 | 1.02-1.10 | .01 | .97 | .90-1.05 | .43 |
| Smoking | .98 | .92-1.04 | .5 | .73 | .42-1.24 | .24 | 1.10 | .49-2.46 | .82 |
| Contraception | .63 | .40-1.75 | .63 | .93 | .40-2.14 | .86 | .58 | .15-2.26 | .43 |
| B-cell phenotype | 1.24 | .82-1.88 | .31 | 1.31 | .82-2.09 | .25 | 1.21 | .58-2.52 | .61 |
| CNS involvement | .58 | .23-1.49 | .26 | .46 | .14-1.49 | .19 | .88 | .20-3.77 | .86 |
| WBC count at diagnosis, ×109/L | .99 | .99-1.00 | .46 | .99 | .99-1.00 | .14 | 1.00 | .99-1.01 | .34 |
| Hemoglobin level at diagnosis, g/dL | 1.05 | .98-1.12 | .19 | 1.00 | .93-1.06 | .93 | 1.17 | 1.03-1.33 | .01 |
| Platelet count at diagnosis/100 × 109/L | 1.02 | 1.00-1.04 | .03 | 1.02 | 1.00-1.04 | .07 | 1.01 | .98-1.05 | .54 |
| Prothrombin ratio at diagnosis, % | 1.00 | .99-1.02 | .23 | 1.00 | .99-1.03 | .15 | .99 | .98-1.02 | .95 |
| Fibrinogen level at diagnosis, g/L | .99 | .98-1.01 | .77 | .99 | .98-1.01 | .80 | .97 | .80-1.19 | .80 |
| Overt DIC | .31 | .08-1.32 | .11 | .44 | .10-1.86 | .26 | — | — | .99 |
| Poor early PB blast clearance, % | .63 | .37-1.07 | .09 | .68 | .38-1.22 | .20 | .45 | .16-1.31 | .14 |
| . | Univariable analysis of risk factors for any thrombosis . | Univariable analysis of risk factors for DVT/PE . | Univariable analysis of risk factors for CVT . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | OR . | 95% CI . | P . | OR . | 95% CI . | P . | OR . | 95% CI . | P . |
| Age | 1.02 | 1.00-1.03 | .03 | 1.03 | 1.00-1.04 | .01 | .99 | .97-1.02 | .57 |
| Female | 1.50 | 1.00-2.23 | .05 | 1.32 | .84-2.08 | .23 | 1.54 | .76-3.13 | .23 |
| BMI | 1.04 | 1.00-1.08 | .05 | 1.06 | 1.02-1.10 | .01 | .97 | .90-1.05 | .43 |
| Smoking | .98 | .92-1.04 | .5 | .73 | .42-1.24 | .24 | 1.10 | .49-2.46 | .82 |
| Contraception | .63 | .40-1.75 | .63 | .93 | .40-2.14 | .86 | .58 | .15-2.26 | .43 |
| B-cell phenotype | 1.24 | .82-1.88 | .31 | 1.31 | .82-2.09 | .25 | 1.21 | .58-2.52 | .61 |
| CNS involvement | .58 | .23-1.49 | .26 | .46 | .14-1.49 | .19 | .88 | .20-3.77 | .86 |
| WBC count at diagnosis, ×109/L | .99 | .99-1.00 | .46 | .99 | .99-1.00 | .14 | 1.00 | .99-1.01 | .34 |
| Hemoglobin level at diagnosis, g/dL | 1.05 | .98-1.12 | .19 | 1.00 | .93-1.06 | .93 | 1.17 | 1.03-1.33 | .01 |
| Platelet count at diagnosis/100 × 109/L | 1.02 | 1.00-1.04 | .03 | 1.02 | 1.00-1.04 | .07 | 1.01 | .98-1.05 | .54 |
| Prothrombin ratio at diagnosis, % | 1.00 | .99-1.02 | .23 | 1.00 | .99-1.03 | .15 | .99 | .98-1.02 | .95 |
| Fibrinogen level at diagnosis, g/L | .99 | .98-1.01 | .77 | .99 | .98-1.01 | .80 | .97 | .80-1.19 | .80 |
| Overt DIC | .31 | .08-1.32 | .11 | .44 | .10-1.86 | .26 | — | — | .99 |
| Poor early PB blast clearance, % | .63 | .37-1.07 | .09 | .68 | .38-1.22 | .20 | .45 | .16-1.31 | .14 |
Platelet count at diagnosis is reported as the platelet count divided by 100.
DIC, diffuse intravascular coagulation.